1. Prevalence of Histoplasmosis among Persons with Advanced HIV Disease, Nigeria.
- Author
-
Oladele, Rita O., Osaigbovo, Iriagbonse I., Akanmu, Alani S., Adekanmbi, Olukemi A., Ekeng, Bassey E., Mohammed, Yahaya, Alex-Wele, Mary A., Okolo, Mark O., Ayanbeku, Stephen T., Unigwe, Uchechukwu S., Akase, Iorhen E., Dan-Jumbo, Alali, Isralski, Dennis, Denning, David W., Pasqualotto, Alessandro C., and Chiller, Tom
- Subjects
- *
HISTOPLASMOSIS diagnosis , *HIV infection epidemiology , *HIV infection complications , *CROSS-sectional method , *FUNGI , *DISEASE prevalence , *HISTOPLASMOSIS - Abstract
We sought to determine the prevalence of probable disseminated histoplasmosis among advanced HIV disease (AHD) patients in Nigeria. We conducted a cross-sectional study in 10 sites across 5 of 6 geopolitical zones in Nigeria. We identified patients with urinary samples containing CD4 cell counts <200 cells/mm3 or World Health Organization stage 3 or 4 disease who also had >2 clinical features of disseminated histoplasmosis, and we tested them for Histoplasma antigen using a Histoplasma enzyme immune assay. Of 988 participants we recruited, 76 (7.7%) were antigen-positive. The 76 Histoplasma antigen-positive participants had significantly lower (p = 0.03) CD4 counts; 9 (11.8%) were also co-infected with tuberculosis. Most antigen-positive participants (50/76; 65.8%; p = 0.015) had previously received antiretroviral treatment; 26/76 (34.2%) had not. Because histoplasmosis is often a hidden disease among AHD patients in Nigeria, Histoplasma antigen testing should be required in the AHD package of care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF